Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Guido Francini

Department of Human Pathology and Oncology

Medical Oncology Section

University of Siena

Policlinico Le Scotte

Italy

[email]@unisi.it

Name/email consistency: high

[Claim this account]

Affiliations

Department of Human Pathology and Oncology, Medical Oncology Section, University of Siena, Policlinico Le Scotte, Italy. 2002 - 2008
Division of Medical Oncology, Institut National de la Santé et de la Recherche Médicale Unité d'Immunité Cellulaire Antivirale, Institut Pasteur, Paris, France. 2002

References

Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer. Francini, G., Paolelli, L., Francini, E., Pascucci, A., Manganelli, A., Salvestrini, F., Petrioli, R. Eur. J. Surg. Oncol (2008) [Pubmed]
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Francini, G., Petrioli, R., Montagnani, A., Cadirni, A., Campagna, S., Francini, E., Gonnelli, S. Br. J. Cancer (2006) [Pubmed]
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid. Correale, P., Messinese, S., Marsili, S., Ceciarini, F., Pozzessere, D., Petrioli, R., Sabatino, M., Cerretani, D., Pellegrini, M., Di Palma, T., Neri, A., Calvanese, A., Pinto, E., Giorgi, G., Francini, G. Br. J. Cancer (2003) [Pubmed]
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens. Francini, G., Petrioli, R., Messinese, S., Pozzessere, D., Marsili, S., Correale, P., Sabatino, M., Fiaschi, A.I. Cancer Chemother. Pharmacol. (2002) [Pubmed]
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects. Francini, G., Scardino, A., Kosmatopoulos, K., Lemonnier, F.A., Campoccia, G., Sabatino, M., Pozzessere, D., Petrioli, R., Lozzi, L., Neri, P., Fanetti, G., Cusi, M.G., Correale, P. J. Immunol. (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.